NEW YORK (GenomeWeb) – DermTech announced today that it has been accredited by the New York State Department of Health to provide laboratory services in the state.

As a result, DermTech can provide such services in all 50 states in the US and the District of Columbia. The company operates a CLIA-certified laboratory at its La Jolla, California-based headquarter.

"Receiving this accreditation is a critical achievement, enabling us to provide molecular pathology services to dermatologists and dermapathologists across the country," DermTech CEO John Dobak said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oct
02

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.